ページ内を移動するためのリンクです。

Financial Highlights

*Notice Regarding Change in Fiscal Year
Due to a change in the fiscal year end to December, FY2014, a transitional period for the change, covers nine months from April 1, 2014 to December 31, 2014.
Thus, percentage changes of FY2014 and FY2015 compared to the previous fiscal year are not applicable.

Key Results (Tables)Click to view graphs.

Consolidated Financial Data (JPY billion / % change)

  FY2011 FY2012 FY2013 FY2014* FY2015
Net Sales 1,154.6 1,218.1 1,452.8 1,224.3 1,445.2
2.4% 5.5% 19.3%
Operating Income 148.7 169.7 198.7 196.5 151.8
17.7% 14.1% 17.1%
Ordinary Income 152.1 184.5 215.2 217.2 159.9
18.5% 21.3% 16.7%
Net Income 92.2 122.4 151.0 143.1 84.1
11.9% 32.8% 23.3%
Research and Development
Expenditure
159.2 192.4 249.0 172.9 201.0
-3.3% 20.8% 29.4%
  FY2011 FY2012 FY2013 FY2014 FY2015
Total Assets 1,666.8 1,779.2 2,028.4 2,178.2 2,528.5
Net Assets 1,222.8 1,325.1 1,510.8 1,658.6 1,683.4
Equity Capital Ratio 72.5 73.7 73.2 74.7 65.4

Geographical Segment Sales

  FY2015 (JPY billion) % of Net Sales
Japan 639.5 44.3
North America 465.6 32.2
Others 340.2 23.5
Sales to customers by market are shown.

Sales by Business Segment

  FY2015 (JPY billion) % of Net Sales
Pharmaceutical business 971.8 67.2
Nutraceutical business 321.6 22.3
Consumer products business 42.9 3.0
Other business 109.0 7.5
Sales to customers by market are shown.

Key Management Indicators

  FY2011 FY2012 FY2013 FY2014 FY2015
ROE (Return on equity: %) 7.8% 9.7% 10.8% 9.2% 5.1%
EPS (Earnings per share: yen) 165.2 221.9 278.1 264.1 155.1
Annual dividends per share (yen) 45.0 58.0 65.0 75.0 100.0
Payout ratio (%) 27.2% 26.1% 23.4% 28.4% 64.5%

Key Results (Graphs)Click to view tables.

  • Graph:Net Sales

  • Graph:Operating Income

  • Graph:Ordinary Income

  • Graph:Research and Development Expenditure

  • Graph:Geographical Segment Sales

  • Sales by Business Segment